Back to search
FDAFDA · Food and drugs·Recall number D-0183-2025

Methadone Hydrochloride Tablets, USP, 5mg, 10x10 Unit-Dose Tablets, Rx Only, Distributed by: Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ 07922, NDC 0054-0709-20

Published January 15, 2025 · Recall initiated: December 19, 2024

Summary

FDA records drug Class III recall D-0183-2025, published January 15, 2025 and initiated December 19, 2024. Recalling firm: West-Ward Columbus Inc; Status: Ongoing; Reported quantity: 2591 100-count boxes; Lot: Lot # AC2556A; Exp. 03/2027. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Tablet/Capsule Specifications: Illegible product identification for the unit dose configuration only.

What to do

Voluntary: Firm initiated · Letter

Get an email if METHADONE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
METHADONE HYDROCHLORIDE
Manufacturer
West-Ward Columbus Inc
Distributor
US Nationwide.
UPC
0300540709259
Lot
Lot # AC2556A; Exp. 03/2027
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Methadone Hydrochloride Tablets, USP, 5mg, 10x10 Unit-Dose Tablets, Rx Only, Distributed by: Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ 07922, NDC 0054-0709-20 recalled?

Yes. FDA published recall D-0183-2025 on January 15, 2025. Reported hazard: Failed Tablet/Capsule Specifications: Illegible product identification for the unit dose configuration only.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: METHADONE HYDROCHLORIDE. UPC: 0300540709259.